Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of sublingual immunotherapy started during the pollen season.
Ariano R, Incorvaia C, La Grutta S, Marcucci F, Pajno G, Sensi L, Di Cara G, Sieber J, Yacoub MR, Frati F. Ariano R, et al. Among authors: di cara g. Curr Med Res Opin. 2009 Jan;25(1):103-7. doi: 10.1185/03007990802591673. Curr Med Res Opin. 2009. PMID: 19210143
Effects of sublingual immunotherapy on allergic inflammation.
Incorvaia C, Frati F, Puccinelli P, Marcucci F, Di Cara G, Sensi L, Scurati S, Yacoub MR, Moingeon P. Incorvaia C, et al. Among authors: di cara g. Inflamm Allergy Drug Targets. 2008 Sep;7(3):167-72. doi: 10.2174/187152808785748191. Inflamm Allergy Drug Targets. 2008. PMID: 18782023 Review.
Effects of sublingual immunotherapy on allergic inflammation: an update.
Yacoub MR, Colombo G, Marcucci F, Caminati M, Sensi L, Di Cara G, Frati F, Incorvaia C. Yacoub MR, et al. Among authors: di cara g. Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):285-91. doi: 10.2174/187152812800958988. Inflamm Allergy Drug Targets. 2012. PMID: 22506880 Review.
129 results